GSK3B and Parkinson disease: In PD striatum [Figure 3D], robust increases were seen in the majority of the Tau kinases: p-GSK-3β, p-JNK, p-p38MAPK, and cdk5, including increases in its p35 and p25 activator proteins and in PKA.